Contact Us  
   
   
   
 
CDT® Supporting Literature and Publications
 
 

 

Research Presentations
Supporting Publications
Bibliography

Note:  Resolution has been reduced to accomodate file download.  File sizes vary.  Download speed will depend on connection speed.  For reprints, high resolution files or information, please contact SCOLR Pharma, Inc.

Select Research Presentations

   
  Company Whitepapers and Development Updates
   
Top Line Results for Pivotal Phase III Clinical Trial 12-Hour Ibuprofen 600 mg CDT® Tablets
   
Ibuprofen Update Whitepaper 06-10-2008
   
CDT® Raloxifene Review Whitepaper 10-31-2006
   
  From AAPS annual meeting 2008
   
Development of A Self-Emulsifying Raloxofene HCI Liquid Formulation
   
Effect of Permeability Enhancers for Polar Drug Transport Across Caco-2 Cell Monolayers
   
Design of a Controlled-Release Naproxen Sodium Solid Oral Dosage
   
Encapsulation as a Means to Control the Release of Oil and Improve Shelf Life Stability
   
Sinker Evaluation of "Mini-Tablet" Filled Capsules of an Extended-Release Formulation
   
Formulation of "Mini-Tablets" in a Capsule for Alternate Routes of Administration
   
Development of Fenofibrate Immediate-Release Tablets Using Hot-Melt Technology
   
Evaluation of the Geometric Proportionality of a Sustained-Release Ibuprofen Matrix Tablet
   
  From CRS annual meeting 2007
   
Viscometry, a Method for Assessing Rate-Controlling Excipients
   
A Bioequivalent 120mg Pseudoephedrine HCI Extended-Release Monolithic Tablet
   
Design of a Monolithic Controlled Release Forumulation of Ondansetron HCI for Oral Administration
   
Evaluation of the Ninhydrin Assay for Gabapentin Determination
   
Scalability Evaluation of Monolithic Controlled Release Gabapentin Formulations for Oral Administration
   
Novel Design of Three Oral Controlled Release Formulations of Phenylephrine HCI
   
  From CRS annual meeting 2005
   
 
In Vivo and In Vitro Performance of a Novel Self-Correcting 600mg 12-hour Controlled Release Formulation of Ibuprofen
 
Novel Design of a Monolithic Controlled Release Formulation of Phenylephrine HCl for Oral Administration
   
  From AAPS annual meeting 2004
   
Investigation of the Robustness of USP and Modified-USP Methods of Weighting Floatable Dosage Forms during Dissolution
   
Robustness of bifurcated Tablet Sections and Influence of Tooling Shape on Release Kinetics of Novel Self-Correcting Hydrophilic Matrix Formulations
   
Scale-up Operation of a Novel Monolithic Controlled Release Tablet Formulation
   
Stressed Stability Studies of Granulated Metronidazole, Tetracycline HCl, Famotidine and Colloidal Bismuth Subcitrate
   
Development of A Tri-Layered Gastroretentive Delivery System for the Treatment of H. pylori Associated Ulcer
   
 

From CRS annual meeting 2004

   
Method for Dissolution Profile Determination of Probiotic Bacteria from Controlled Release Solid Oral Dosage Forms
   
  From AAPS annual meeting 2003
   
In Vitro Investigations Of Alternative Controlling Polymer Formulations Of A Novel, Self-correcting Controlled Release Matrix Displaying BA/BE To A Reference-listed Product
   
Formulation Development Of A Novel Self-correcting Controlled Release Matrix System Incorporating Film-forming Polymer Coatings
   
Novel Design Of An Oral Monolithic Controlled Release Delivery System For Branded Active Materials
   
  From AAPS annual meeting 2002
   
Novel Design of a Monolithic Oral Controlled-Release Delivery Formulation for Probiotic Organisms
   
Novel Design of a Robust and Rugged Oral Monolithic Controlled Release Delivery System for Tramadol Hydrochloride
   
Novel Design of a Monolithic Oral Controlled-Release Delivery Formulation for Novasoy® Soy Isoflavone Concentrate
   
In-situ Solubilization of Class II Drugs During the Hydrosol-Gelation Phase in the Presence of Amphoteric Amino Acids, Polysaccharides, and Polymers: A Novel Approach in Controlled Release Drug Delivery
   
In Vivo - In Vitro correlation (IVIVC) of a novel monolithic controlled release dosage form: Niacin CR Delivery System
   
  From AAPS annual meeting 2001
   
Low Cost High-Load Monolithic Controlled Release Oral Delivery System for Nutraceuticals
   
Development of a High Drug Load Monolithic Controlled Release Oral Delivery System for Niacin: A Novel Approach
   
Novel Design of a Cost-Effective Monolithic Controlled Release Decongestant
 

 

 
 

Supporting Publications

   
  Recent Peer Reviewed Publications:
  S. Turner, C. Federici, M. Hite and R Fassihi
Formulation development and human in vitro-in vivo correlation for a novel monolithic controlled release matrix system of high load and highly water soluble drug Niacin. Drug Development and Industrial Pharmacy, Vol. 30, No. 8, pp. 797-807, 2004.
  For Reprint, Contact info@scolr.com.
   
 

Selected articles from PMPS, Pharmaceutical Manufacturing and Packing Sourcer:

   
Controlled Delivery Oral Dosage Forms in the New Millennium
655k
   
Part 1: Oral Delivery of Poorly Soluble Drugs
198k
   
Part 2: Oral Delivery of Poorly Soluble Drugs
226k
   
Controlled Delivery Technologies Applied to the Nutraceutical Industry
178k
   
 

Selected articles from Drug Delivery Technology:

Drug Delivery Technology interview with SCOLR Pharma, Inc., March 2008
   
Novel Design of a Self-Correcting Monolithic Controlled-Release Delivery System for Tramadol
   
Formulation Forum: Controlled Release gets Smarter; Thanks To Nanotechnology.
   
  Selected articles from Pharmaventures Business Briefings:
   
Improving Adherence in the Polypharmacy Management of Disease
   
   

Bibliography

CHAPTERS IN BOOKS

  1. A. R. FASSIHI and M. S. PARKER: Chapter 6: Controlled Drug Delivery, In Pharmaceutical Technology: Controlled drug release. Vol. 1, Ed. M. H. Rubinstein, Ellis Horwood Ltd., John Wiley & Sons, UK(1987) pp 64-71.
  2. A. R. FASSIHI and I KANFER: Chapter 16: The effect of compressibility and powder flow properties on tablet weight variation; in Pharmaceutical Technology, Tableting Technology, M. H. Rubinstein, John Wiley & Sons, UK (1987) pp 189-202.
  3. A. R. FASSIHI.
    Preservation of medicines against microbial contamination, in: Chapter 50: 4th. Edition ; Disinfection, Sterilization and Preservation; Ed. S. S. Block, Lea & Febiger, Philadelphia, USA. (1991) pp 871-886.
  4. REZA FASSIHI
    Preservation and Microbiological Attributes of Non-Sterile Pharmaceutical Products, Chapter 64: In 5th Edition of Disinfection, Sterilization and Preservation; Ed. Seymour S. Block, Ph.D. Lippincott Williams and Wilkins 2000, pp 1263-1281.

PEER REVIEWED FULL PUBLICATIONS IN JOURNALS; AND PAPERS PUBLISHED IN VARIOUS CONFERENCE PROCEEDINGS

  1. A. R. FASSIHI, M. S. PARKER and N. POURKAVOOS.
    Controlled release delivery: effect of particle size, compression force and temperature. Proceedings of the 4th. Pharm. Tech. Conference, Edinburgh, Scotland, April (1984), 10-12.
  2. A. R. FASSIHI.
    A new generation of polymers for controlled drug delivery. S.A.J. Sci., 81:586, (1985).
  3. A. R. FASSIHI, M. S. PARKER and N. POURKAVOOS.
    Solid dispersion controlled release: Effect of particle size compression force and temperature. Drug Development and Industrial Pharmacy, Vol. II: Nos 2 and 3: 523-535 (1985).
  4. A. R. FASSIHI.
    Compression characteristics of polymers in tablet formulations. 5th. Int. Pharm. Tech. Conference, Harrogate, England (1986), Vol II: 222- 227.
  5. A. R. FASSIHI and M. S. PARKER
    Release kinetics from heterogenous polymeric matrices. 5th. Int. Pharm. Tech. Conference, Harrogate, England (1986), pp 97-111.
  6. A. R. FASSIHI and I. KANFER.
    Effect of compressibility and powder flow properties on tablet weight variation. Drug Development and Ind. Pharm. 12 (11-13), 1947, (1986).
  7. A. R. FASSIHI and I. KANFER.
    Compressibility and powder flow properties. 5th. Int. Pharm. Tech. Conference, Harrogate, England, 255-275 (1986).
  8. A. R. FASSIHI.
    Mechanisms of disintegration and compactibility in a direct compression system. International Journal of Pharmaceutics, 32 (1986), 93-96.
  9. A. R. FASSIHI.
    Continuous matrix formation for controlled drug release: compression of isotropic polymeric system. International Journal of Pharmaceutics, 34 (1986) 169-172.
  10. A. R. FASSIHI and M. S. PARKER.
    Controlled drug release from a compressed heterogeneous polymeric matrix: kinetics of release. Drug Develop and Ind. Pharm. 12 (11-13), 1649- 1661 (1986).
  11. A. R. FASSIHI.
    Kinetics of drug release from solid matrices. International Journal of Pharmaceutics, 37 (1987) 119-125.
  12. A. R. FASSIHI and M. S. PARKER.
    Gamma irradiation of gelatin: effects on the rigidity index and the granulation process. Seventh International Biodeterioration symposium Cambridge, UK Sept. (1987), Elsevier Science Publishers BV.
  13. A. R. FASSIHI.
    Hydrogel: A novel disintegrant in tablet formulation. J. Pharm. Pharmacol. (1987) 129S.
  14. A. R. FASSIHI.
    Consolidation behavior of polymeric substances in non-disintegrating solid matrices. International Journal of Pharmaceutic (1988) 44, 249-256.
  15. A. R. FASSIHI.
    Interrelationships between yield pressure, moisture content and tensile strength of microcrystalline cellulose compacts. J. Pharm. Pharmacol. (1988) 76P.
  16. A. R. FASSIHI.
    in vitro and in vivo evaluation of controlled release preparation of theophylline. J. Pharm. Pharmacol. (1988), 32P.
  17. A. R. FASSIHI, R. DOWSE and S. D. ROBERTSON.
    Effects of dietary cellulose on the absorption and bioavailability of theophylline. Int. J. Pharmaceutics (1989), 41: 369-372.
  18. A. R. FASSIHI and D. L. MUNDAY.
    Dissolution of theophylline from film coated slow release mini-tablets in various dissolution media. J. Pharm. Pharmacol. (1989), 41: 369-372.
  19. D. L. MUNDAY and A. R. FASSIHI.
    Controlled release delivery: Effect of coating composition on release characteristics of mini-tablets. Int. J. Pharmaceutics, (1989), 52, 109-114.
  20. D. L. MUNDAY and A. R. FASSIHI.
    Changes in drug release rate; effect of temperature asnd relative humidity on polymeric film coatings, 5th. Int. Pharm. Confr. Paris, June (1989), Vol. II. 55-60.
  21. A. R. FASSIHI.
    Characteristics of hydrogel in solid dosage technology. J. Pharm. Pharmacol. (1989), 41: 853-855.
  22. REZA FASSIHI
    Biopharmaceutical aspects of drug formulations S.A.Pharm.J. (1990), 5:151-156.
  23. REZA FASSIHI
    Biopharmaceutical aspects of intestinal drug absorption S.A.Pharm.J. (1990), 7:259-265.
  24. D. L. MUNDAY, A. R. FASSIHI and C. DeVILLIERS.
    Bioavailability study of a theophylline oral controlled release capsule containing film coated mini-tablets in beagle dogs. International J. Pharmaceutics, Vol. 69: 123-127 (1991).
  25. A. R. FASSIHI, ROSE DOWSE, SIRION S. D. ROBERTSON.
    Influence of sorbitol solution on the bioavailability of theophylline. Int. J. Pharm. 72 (1991) 175-178.
  26. D. L. MUNDAY, A. R. FASSIHI and C. DeVILLIERS.
    Multiple dose in vivo evaluation of an oral controlled release capsule dosage form of theophylline containing film coated mini-tablets in beagle dogs. Int. J. Pharm. 73 (1991) 89-93.
  27. M. DANCKWERTS and A. R. FASSIHI.
    Implantable controlled release drug delivery systems. Drug Develop and Ind. Pharm. 17 (11), 1465-1502 (1991).
  28. D. L. MUNDAY and A. R. FASSIHI.
    Changes in drug release rate: effect of stress storage conditions on polymeric film coated mini-tablets. Drug Develop. Ind. Pharm. 17 (15), 2135-2143 (1991).
  29. T. DURIG and A. R. FASSIHI.
    Preformulation study of moisture effect on the physical stability of pyridoxal hydrochloride. Int. J. Pharm., 77, 315-319 (1991).
  30. W. A. RITSCHEL, N. N. VACHHARAJANI, H. FORUSZ and A. R. FASSIHI.
    On the Mechanism of effect of fatty acids on gastric emptying. Proceedings of the I Reunion cientifica de'la Association de Docentes de'Farmacia Galenica: Madrid, Spain p. p. 27-28 (1992).
  31. A. R. FASSIHI and E. A. RITSCHEL
    Multiple-layer, direct compression, controlled release system: in vitro and in vivo evaluation. J. Pharm. Sci. Vol. 82, No. 7, 750-754 (1993).
  32. D. L. MUNDAY and A. R. FASSIHI
    Changes in drug release rate 2: effect of temperature and relative humidity on polymeric film coatings. 5th International Conference on Pharmaceutical Technology Paris May 30th - June 1, 1989, 55-60.
  33. T. DURIG and A. R. FASSIHI
    Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid dosage form design. Int. J. Pharm. 97, 161-170, (1993).
  34. W. A. RITSCHEL, N. N. VACHHARARAJANI, and A. R. FASSIHI.
    In-vitro model optimization of antacid evaluation based on physiological constraints and human gastric pH. Pharm. Pharmacol. Lett. 2:58-61 (1992).
  35. R. FASSIHI
    Microporous mini-tablets for controlled delivery and fine dose titration. Proceed. 20th. Intern. Symp. Control. Rel. Bioact. Mater., Washington, D.C. pp. 388-389 (1993).
  36. R. FASSIHI
    Fluctuating release rate delivery system for drugs influenced by chronobiologic functions. Proceed. 20th. Intern. Symp. Control. Rel. Bioact. Mater., Washington, D.C. pp. 38-39 (1993).
  37. R. FASSIHI, A.M. McPHILLIPS, S.A. URAIZEE and A.M. SAKR
    Potential Use of Magnesium Stearate and Talc as Dissolution Retardants in the Development of Controlled Drug Delivery Systems. Pharm. Ind., 56, 6, 579-583 (1994).
  38. D. L. MUNDAY and A. R. FASSIHI
    In-vitro - in-vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets. Int. J. Pharm., 118-251-255 (1995).
  39. L. YANG and R. FASSIHI
    Zero-order release kinetics from self-correcting floatable asymmetric configuration drug delivery system. J. Pharm. Sci. 85, 170-173 (1996).
  40. R. FASSIHI, J. FABIAN and A M. SAKR.
    Application of Response Surface Methodology to design optimization in formulation of a typical controlled release system. Pharm. Industry,57, 12, 1039-1043 (1995).
  41. L. YANG, G. VENKATESH, AND R. FASSIHI
    Characterization of Compressibility and Compactibility of Poly(ethylene oxide) Polymers for Modified Release Application by Compaction Simulator. J. Pharm. Sci. 85, 1085-1090 (1996).
  42. L. YANG and R. FASSIHI
    Modulation of diclofenac release from a totally soluble controlled release drug delivery system. Journal of Controlled Release 44, 135-140 (1997)
  43. REZA FASSIHI, AMIR RAZAGHI, HYUNJO KIM, LIBO YANG, JUNE FABIAN
    Pitfalls in Release Studies of Floatable or Sticking Delivery Systems Proceedings of Controlled Release Society, Baltimore, August, 121-122 (1996).
  44. LIBO YANG AND REZA FASSIHI
    Diclofenac Delivery System Design Based on Biopharmaceutical Considerations Proceedings of Controlled Release Society, Baltimore, August, 123-124 (1996).
  45. HYUNJO KIM AND REZA FASSIHI
    Optimal Delivery System for Colonic Drug Targeting Proceedings of Controlled Release Society, Baltimore, August, 125-126 (1996).
  46. AMIR M. RAZAGHI AND REZA FASSIHI
    Evaluation of Diffusion Controlled Release From Topical Steroid Products Proceedings of Controlled Release Society, Baltimore, August, 127- 128 (1996).
  47. R. FASSIHI, J. FABIAN AND A.M. SAKR
    Application of Response Surface Methodology to Design Optimization in Formulation of a Typical Controlled Release System. Drugs made in Germany 39, 122-126 (1996).
  48. HYUNJO KIM AND REZA FASSIHI
    Ternary Polymeric Matrix System a New Approach in Controlled Release. Drug Delivery of Highly Soluble Drugs: I-Diltiazem Hydrochloride. Pharm. Res. Vol. 14, No. 10, 1415-1421 (1997).
  49. HYUNJO KIM AND REZA FASSIHI
    Application of Binary Polymer System in Drug Release Rate Modulation: I -Characterization of Release Mechanism J. Pharm. Sci, 86, 316-322 (1997).
  50. HYUNJO KIM AND REZA FASSIHI
    Application of Binary Polymer System in Drug Release Rate Modulation: II - Influence of Formulation Variables and Hydrodynamic Conditions on Release Kinetics. J. Pharm. Sci, 86, 323-328 (1997).
  51. HYUNJO KIM, GOPI VENKATESH AND REZA FASSIHI
    Compactiblity Characterization of Granular Pectin for tableting operation using a compaction simulator Int. J. Pharm. 161, 149-159 (1998)
  52. LIBO YANG AND REZA FASSIHI
    Examination of Drug, Polymer, Hydrodynamics and Compositional Effects on Release Rate from a triple-layer Asymmetric Configuration Delivery System Int. J. Pharm. 155 , 219-229 (1997).
  53. LIBO YANG, GOPI VENKATESH AND REZA FASSIHI
    Compaction Simulator Study of a Novel Triple-Layer Matrix for industrial Tableting. Int. J. Pharm. 152 , 45-52 (1997).
  54. THOMAS DURIG AND REZA FASSIHI
    Mechanistic Evaluation of Binary Effects of Magnesium Stearate and Talc as Dissolution Retardants at 85% Drug Loading in an Experimental Extended Release Formulation. J. Pharm. Sci., 86, No. 10, 1092-1098 (1997).
  55. LIBO YANG AND REZA FASSIHI
    Verapamil Delivery System based on biopharmaceutical considerations. 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, June 15-19, (1997).
  56. V. PILLAY AND R. FASSIHI
    Evaluation and comparison of dissolution data dervied from different modified release dosage forms: An alternative method. J. Controlled Rel., 55, 45-55 (1998).
  57. L. YANG, B. JOHNSON AND R. FASSIHI
    Determination of continuous changes in thegel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: Application of Texture Analyzer. Pharm. Res. 15, 1902-1906 (1998).
  58. L. YANG , J. ESHRAGHI, AND R. FASSIHI
    A new system for controlled and concomitant intragastric delivery of tetracycline, metronidazole and bismuth salts for the treatment of Helicobater pylori associated gastric ulcer J. Controlled Rel. 57, 215-222 (1999).
  59. V. PILLAY AND R. FASSIHI
    In-vitro release modulation for site-specific drug delivery to the gastrointestinal tract I : Comparison of pH-responsive drug release and associated kinetics. J. Controlled Rel. 59, 229-242 (1999).
  60. V. PILLAY AND REZA FASSIHI
    In-vitro release modulation for site -specific drug delivery to the gastrointestinal tract II : Physicochemical characterization of calcium-alginate,calcium-pectinate and alginate-pectinate pellets. J. Controlled Rel. 59, 243-256 (1999).
  61. V. PILLAY AND REZA FASSIHI
    A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug. Pharm. Res. 16, 333-337 (1999).
  62. V. PILLAY AND REZA FASSIHI
    Unconventional dissolution methodologies. J. Pharm. Sci., vol. 88, 9, 843-851 (1999).
  63. T. DURIG AND REZA FASSIHI
    Functionality of a high drug load particulate system designed for an erodible extended release matrix tablet II: Effect of compaction variables and lubricant levels on drug release. J. Pharm.and Pharmacol. (in press).
  64. T. DURIG, G.M. VENKATESH AND REZA FASSIHI
    An investigation into the erosion behaviour of a high drug- load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compactionrate. J. Pharm. Pharmacol., 55: 1085-1092 (1999).
  65. V. PILLAY AND REZA FASSIHI
    Electrolyte- induced compositional heterogeneity in tablet matrix for rate-controlled drug delivery. J.Pharm.Sci., Vol.88, No.11, 1140-1148 (1999).
  66. V. PILLAY AND REZA FASSIHI
    In-situ electrolyte interactions in a disk compressed configuration system for up-curving and constant release kinetics. J. Controlled Release, 67, 55-65, (2000).
  67. V. PILLAY AND REZA FASSIHI
    Zero order delivery of a 100% water soluble drug from a directly compressed monolithic system: Metoprolol tartarate. J. Controlled Release, 67, 67-78 (2000).
  68. THOMAS DURIG AND REZA FASSIHI
    Evaluation of Floating and Sticking Extended Release delivery Systems: An Unconventional Dissolution Test. J.Controlled Release, 67, 37-44, (2000).
  69. V. PILLAY AND REZA FASSIHI
    Probing the dynamics of matrix hydration in the presence of electrolytes. Drug Delivery, 8; 87-92, (2001).
  70. S. ZULEGER, R. FASSIHI AND B. C. LIPPOLD
    Texture Analysis and Photomicroscopy to Investigate the Swelling of Controlled Release Cellulose Ether Tablets. European J.Pharm. Sci.; Accepted for publication 2002.
  71. T.DURIG AND REZA FASSIHI
    Gar-based monolithic matrix systems: Effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. Journal of Controlled Release, Vol. 80 (1-3) pp 45-56, 2002.
  72. V. PILLAY, M.P. DANKWERTS AND REZA FASSIHI
    A crosslinked calcium-alginate-pectinate-cellulose acetophthalate gelisphere system for linear drug release. Drug Delivery, 9:77-86, (2002).
  73. S. ZULEGER, R. FASSIHI AND B. LIPPOLD
    Polymer particle erosion controlling drug release. II. Swelling investigations to clarify the release mechanism. International Journal of Pharmaceutics, 247, 23-37 (2002).
  74. S. Turner, M. Hite, C. Federici and Reza Fassihi
    Development of a High Drug Load Monolithic Controlled Release Oral Delivery System for Niacin: A Novel Approach Drug Delivery Technology; Vol. 3; No. 2; March/April issue, 2003.
  75. T. DURIG, G.M. VENKATESH AND REZA FASSIHI
    Compactibility of a high drug load (85%) agglomerated system designed for an extended release matrix tablet: Effect of variations in lubricant level, porosity and compaction rate. J. Pharm. Pharmacol. (submitted for publication).
  76. R. Talukder and Reza Fassihi
    GASTRORETENTIVE DELIVERY SYSTEMS: HOLLOW BEADS. Drug Development and Industrial Pharmacy (submitted for publication).
  77. R. Talukder, and R. Fassihi
    GASTRORETENTIVE DELIVERY SYSTEMS: A MINI REVIEW Drug Development and Industrial Pharmacy (submitted for publication).
  78. S. Turner, C. Federici, M. Hite and R Fassihi
    Formulation development and human in vitro-in vivo correlation for a novel monolithic controlled release matrix system of high load and highly water soluble drug Niacin. Drug Development and Industrial Pharmacy, Vol. 30, No. 8, pp. 797-807, 2004.